文献速递肝病消化道肿瘤与早癌

硒蛋白P缺乏通过诱导中性粒细胞衰老和免疫抑制微环境驱动肝细胞癌进展

Selenoprotein P deficiency drives hepatocellular carcinoma progression via induction of neutrophil senescence and immunosuppressive microenvironment.
PubMed 文献 · Gut · 2026-04-01

该研究通过单细胞RNA测序分析肝细胞癌小鼠模型,发现Sepp1缺失经Lrp8介导的硒摄取障碍抑制硒代谢,导致中性粒细胞衰老样重编程和免疫抑制。补硒可逆转上述效应并协同抗PD-1治疗抑制肿瘤生长。

要点

  • 肝癌微环境中Sepp1缺乏驱动衰老样中性粒细胞积聚并促进免疫抑制。
  • Sepp1缺失经Lrp8转运障碍抑制硒代谢,通过表观遗传重塑诱导中性粒细胞衰老。
  • 补硒可恢复Sepp1表达、减少中性粒细胞衰老重编程并增强抗PD-1疗效。

核心结论

  • Sepp1是肝细胞癌中通过硒依赖性表观遗传重塑调控中性粒细胞衰老重编程和免疫抑制的关键调节因子。
  • 通过补硒靶向衰老样中性粒细胞有望增强肝癌免疫治疗疗效。

研究设计与样本

  • 在肝细胞癌小鼠模型中进行整合单细胞RNA测序分析,并结合功能、代谢和表观遗传学实验表征中性粒细胞亚群及调控通路。

主要发现

  • 鉴定出一群衰老样肿瘤浸润中性粒细胞亚群,以Sepp1肝脏缺失、Cdkn1a、S100a8/9和Vegfa升高为标志。
  • 肿瘤来源Sepp1缺失经Lrp8介导的转运损害硒摄取,抑制细胞内硒代谢和硒化氢产生。
  • 上述改变导致S-腺苷甲硫氨酸积聚和组蛋白H3第4位赖氨酸三甲基化修饰增加,驱动促衰老染色质景观。
  • 补硒可逆转这些效应,恢复Sepp1表达、减少中性粒细胞衰老相关重编程并重振抗肿瘤免疫。
  • 硒与抗程序性死亡受体1治疗协同抑制肿瘤生长。

临床怎么用

  • 补硒可能作为靶向衰老样中性粒细胞的策略,用于增强肝癌抗PD-1免疫治疗疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The hepatocellular carcinoma (HCC) immune microenvironment is heavily influenced by immunosuppressive neutrophils, yet the mechanisms driving their senescence-associated reprogramming remain elusive. OBJECTIVES: To elucidate the role of Selenoprotein P (Sepp1)-mediated selenium metabolism in driving the accumulation and immunosuppressive function of senescent-like neutrophils in HCC, and its impact on tumour immune evasion. DESIGN: We performed integrative single-cell RNA sequencing analyses in HCC mouse models, coupled with functional, metabolic and epigenetic assays to characterise neutrophil subpopulations and dissect the regulatory pathways linking Sepp1 and selenium metabolism to neutrophil senescence-associated reprogramming and tumour progression. RESULTS: We identified a distinct subpopulation of senescent-like tumour-infiltrating neutrophils marked by hepatic depletion of Sepp1, elevated Cdkn1a, S100a8/9 and Vegfa. Loss of tumour-derived Sepp1 impaired selenium uptake via Lrp8-mediated transport, suppressing intracellular selenium metabolism and hydrogen selenide production. This led to S-adenosylmethionine accumulation and increased histone H3 protein of trimethylation of lysine 4 histone modification, driving a prosenescence chromatin landscape. Selenium supplementation reversed these effects, restoring Sepp1 expression, reducing neutrophil senescence-associated reprogramming and reinvigorating anti-tumour immunity. Moreover, selenium synergised with anti-programmed cell death 1 therapy to suppress tumour growth. CONCLUSIONS: Sepp1 is a key regulator of neutrophil senescence-associated reprogramming and immune suppression in HCC through selenium-dependent epigenetic remodelling. Targeting senescent-like neutrophils via selenium supplementation holds therapeutic promise to enhance immunotherapy efficacy in liver cancer.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Jiao J, Song L, Xu S, et al. Selenoprotein P deficiency drives hepatocellular carcinoma progression via induction of neutrophil senescence and immunosuppressive microenvironment. Gut. 2026. PMID: 41922101. doi:10.1136/gutjnl-2025-336422

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。